Ralph Schiess
Patrimonio netto: 99 $ in data 31/08/2026
Patrimonio netto: 99 $ in data 31/08/2026
Ralph Schiess was the founder of Proteomedix AG, founded in 2010, and held the title of Chief Executive Officer from 2023 to 2025.
Former job includes Chief Executive & Science Officer at Onconetix, Inc. from 2024 to 2025.
Education includes graduate degree from the University of Zurich and doctorate from the Swiss Federal Institute of Technology.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/03/2026 | 158 ( 0% ) | 99 $ | 31/08/2026 |
| Società | Posizione | Fine |
|---|---|---|
Proteomedix AG
Proteomedix AG BiotechnologyHealth Technology Operates as a private, commercial-stage diagnostics oncology company | Amministratore Delegato | 31/05/2025 |
| ONCONETIX, INC. | Amministratore Delegato | 24/02/2025 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteomedix AG
Proteomedix AG BiotechnologyHealth Technology Operates as a private, commercial-stage diagnostics oncology company | Health Technology |
Onconetix, Inc.
Onconetix, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs and diagnostic test for cancers | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale